Suppr超能文献

在疫情期间接受的任何特殊酒精治疗对患有酒精使用障碍(AUD)或有患AUD风险的患者减少饮酒是否有效?

Was receipt of any specialty alcohol treatment during the pandemic effective at reducing drinking for patients with or at risk of AUD?

作者信息

Kline-Simon Andrea H, Palzes Vanessa A, Chi Felicia W, Satre Derek D, Weisner Constance, Sterling Stacy A

机构信息

Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America.

Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA, 94612-2304, United States of America.

出版信息

J Subst Use Addict Treat. 2025 Jan;168:209531. doi: 10.1016/j.josat.2024.209531. Epub 2024 Oct 6.

Abstract

INTRODUCTION

The COVID-19 pandemic changed the way healthcare providers delivered most health services, including treatment for alcohol use disorder (AUD). Specialty alcohol treatment remained available through the pandemic, and within some systems treatment use increased likely due to telehealth availability. However, the field knows little about the relationship between the pandemic's expanded access to specialty alcohol treatment and alcohol use outcomes.

METHODS

The sample included 14,712 patients from Kaiser Permanente Northern California who screened positive for unhealthy alcohol use in primary care and had an AUD diagnosis or risked developing an AUD by reporting 5 or more heavy drinking days in a 3-month period between 1/1/2019 and 2/29/2020 (pre-pandemic). The study examined the receipt of any specialty alcohol treatment (including at least one outpatient, inpatient, or telehealth specialty treatment encounter, or pharmacotherapy prescription) from 3/1/2020 (pandemic start) to either the first completed follow-up alcohol screening or 6/20/2022 (study period end). The outcomes of alcohol use included changes in heavy drinking days, drinks per week, drinking days per week, and drinks per drinking day between the pre- and post-pandemic periods.

RESULTS

On average patients significantly decreased alcohol use across all four alcohol use measures examined, regardless of whether they received treatment. However, those who received any treatment compared to those who did not had greater reductions in alcohol use, with an additional decrease of -3.55 heavy drinking days (95 % CI = -5.93, -1.17), -3.80 drinks per week (95 % CI = -5.18, -2.42), -0.72 drinks per drinking day (95 % CI = -1.14, -0.30), and - 1.01 drinking days per week (95 % CI = -1.30, -0.72). Treatment effects were greatest among patients who exceeded both daily and weekly limits pre-pandemic, with an additional decrease of -10.75 heavy drinking days (95 % CI = -15.28, -6.21), -12.83 drinks per week (95 % CI = -16.31, -9.35), -1.67 drinks per drinking day (95 % CI = -2.19, -1.14), and -2.02 drinking days per week (95 % CI = -2.41, -1.63).

CONCLUSIONS

On average, patients decreased alcohol use during the onset of the pandemic, however, those who had any specialty alcohol treatment had significantly greater decreases, suggesting that the hybrid in-person and telehealth treatment approach was effective during the pandemic.

摘要

引言

新冠疫情改变了医疗服务提供者提供大多数医疗服务的方式,包括酒精使用障碍(AUD)的治疗。在疫情期间,专科酒精治疗仍然可用,并且在一些系统中,由于远程医疗的可用性,治疗的使用可能有所增加。然而,该领域对疫情期间专科酒精治疗的扩大获取与酒精使用结果之间的关系了解甚少。

方法

样本包括来自北加利福尼亚凯撒医疗集团的14712名患者,他们在初级保健中筛查出不健康饮酒呈阳性,并且在2019年1月1日至2020年2月29日(疫情前)的3个月期间报告有5个或更多重度饮酒日,被诊断为AUD或有患AUD的风险。该研究考察了从2020年3月1日(疫情开始)到首次完成的随访酒精筛查或2022年6月20日(研究期结束)期间接受任何专科酒精治疗(包括至少一次门诊、住院或远程医疗专科治疗接触,或药物治疗处方)的情况。酒精使用的结果包括疫情前后重度饮酒日、每周饮酒量、每周饮酒天数和每次饮酒日饮酒量的变化。

结果

平均而言,无论是否接受治疗,患者在所有四项考察的酒精使用指标上都显著减少了酒精使用。然而,与未接受治疗的患者相比,接受任何治疗的患者酒精使用减少得更多,重度饮酒日额外减少-3.55天(95%置信区间=-5.93,-1.17),每周饮酒量额外减少-3.80杯(95%置信区间=-5.18,-2.42),每次饮酒日饮酒量额外减少-0.72杯(95%置信区间=-1.14,-0.30),每周饮酒天数额外减少-1.01天(95%置信区间=-1.30,-0.72)。治疗效果在疫情前超过每日和每周限量的患者中最为显著,重度饮酒日额外减少-10.75天(95%置信区间=-15.28,-6.21),每周饮酒量额外减少-12.83杯(95%置信区间=-16.31,-9.35),每次饮酒日饮酒量额外减少-1.67杯(95%置信区间=-2.19,-1.14),每周饮酒天数额外减少-2.02天(95%置信区间=-2.41,-1.63)。

结论

平均而言,患者在疫情开始时减少了酒精使用,然而,接受任何专科酒精治疗的患者减少幅度显著更大,这表明面对面和远程医疗相结合的治疗方法在疫情期间是有效的。

相似文献

5
Rates and Impact of Adherence to Recommended Care for Unhealthy Alcohol Use.不健康饮酒行为的遵医率及其影响因素。
J Gen Intern Med. 2019 Feb;34(2):256-263. doi: 10.1007/s11606-018-4749-3. Epub 2018 Nov 27.
6
Baclofen for alcohol use disorder.巴氯芬治疗酒精使用障碍。
Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD012557. doi: 10.1002/14651858.CD012557.pub3.

本文引用的文献

9
Telemedicine in the treatment of addictions.远程医疗在成瘾治疗中的应用。
Curr Opin Psychiatry. 2022 Jul 1;35(4):227-236. doi: 10.1097/YCO.0000000000000795. Epub 2022 Jun 9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验